UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Computed tomography of complicated Meckel's diverticulum in adults

Radiologia, 2019-07, Vol.61 (4), p.297-305

2019

Volltextzugriff (PDF)

1932P First in human trial of CEB-01 for retroperitoneal soft tissue sarcoma

Annals of oncology, 2023-10, Vol.34, p.S1038-S1038

2023

Volltextzugriff (PDF)

Computed tomography of complicated Meckel's diverticulum in adults

Radiología (English ed.), 2019-07, Vol.61 (4), p.297-305

2019

Volltextzugriff (PDF)

Tomografía computarizada del divertículo de Meckel complicado en adultos

Radiología, 2019-07, Vol.61 (4), p.297-305

2019

Volltextzugriff (PDF)

Fístula carotídeo-esofágica por cuerpo extraño

Cirugia Española, 2012-12, Vol.90 (10), p.668-670

2012

Volltextzugriff (PDF)

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

The Journal of infectious diseases, 2014-08, Vol.210 (3), p.354-362

2014

Volltextzugriff (PDF)

Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study

Clinical immunology (Orlando, Fla.), 2014-10, Vol.154 (2), p.141-154

2014

Volltextzugriff (PDF)

Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score

International journal of antimicrobial agents, 2018-03, Vol.51 (3), p.393-398

2018

Volltextzugriff (PDF)

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

The Lancet infectious diseases, 2015-07, Vol.15 (7), p.775-784

2015

Volltextzugriff (PDF)

Identification of potential invasive alien species in Spain through horizon scanning

Journal of environmental management, 2023-11, Vol.345, p.118696-118696, Article 118696

2023

Volltextzugriff (PDF)

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

Journal of antimicrobial chemotherapy, 2017-01, Vol.72 (1), p.246-253

2017

Volltextzugriff (PDF)

Cost-effectiveness of robotic vs laparoscopic distal pancreatectomy. Results from the national prospective trial ROBOCOSTES

Surgical endoscopy, 2024-08

2024

Volltextzugriff (PDF)

Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir

AIDS (London), 2012-11, Vol.26 (18), p.2315-2326

2012

Volltextzugriff (PDF)

High proportion of CD95+ and CD38+ in cultured CD8+ T cells predicts acute rejection and infection, respectively, in kidney recipients

Transplant immunology, 2016-02, Vol.34, p.33-41

2016

Volltextzugriff (PDF)

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study

AIDS (London), 2010-07, Vol.24 (11), p.1697-1707

2010

Volltextzugriff (PDF)

Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion

Journal of antimicrobial chemotherapy, 2021-03, Vol.76 (4), p.1046-1050

2021

Volltextzugriff (PDF)

Search for the Standard Model Higgs boson at LEP

Physics letters. B, 2003-07, Vol.565, p.61-75

Lep Higgs Working Group For Higgs Boson, Searches

2003

Volltextzugriff (PDF)

Targeting body composition in an older population: do changes in movement behaviours matter? Longitudinal analyses in the PREDIMED-Plus trial

BMC medicine, 2021-01, Vol.19 (1), p.3-3, Article 3

2021

Volltextzugriff (PDF)

High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients

Immunobiology (1979), 2016-05, Vol.221 (5), p.595-603

2016

Volltextzugriff (PDF)

O94 NEDDYLATION CONTROLS LIVER TUMOURS SURVIVAL STABILIZING Akt AND LKB1 AND REPROGRAMMING CANCER METABOLISM

Journal of hepatology, 2014-04, Vol.60 (1), p.S39-S39

2014

Volltextzugriff (PDF)

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

Journal of antimicrobial chemotherapy, 2018-09, Vol.73 (9), p.2444-2451

2018

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(35)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Computed tomography of complicated Meckel's diverticulum in adults

1932P First in human trial of CEB-01 for retroperitoneal soft tissue sarcoma

Computed tomography of complicated Meckel's diverticulum in adults

Tomografía computarizada del divertículo de Meckel complicado en adultos

Fístula carotídeo-esofágica por cuerpo extraño

Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study

Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Identification of potential invasive alien species in Spain through horizon scanning

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

Cost-effectiveness of robotic vs laparoscopic distal pancreatectomy. Results from the national prospective trial ROBOCOSTES

Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir

High proportion of CD95+ and CD38+ in cultured CD8+ T cells predicts acute rejection and infection, respectively, in kidney recipients

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study

Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion

Search for the Standard Model Higgs boson at LEP

Targeting body composition in an older population: do changes in movement behaviours matter? Longitudinal analyses in the PREDIMED-Plus trial

Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer

High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients

O94 NEDDYLATION CONTROLS LIVER TUMOURS SURVIVAL STABILIZING Akt AND LKB1 AND REPROGRAMMING CANCER METABOLISM

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

Suchergebnisse filtern